Metoprolol

Metoprolol
Clinical data
Pronunciation	/mɛˈtoʊproʊlɑːl/, /mɛtoʊˈproʊlɑːl/
Trade names	Lopressor, others
AHFS/Drugs.com	Monograph
MedlinePlus	a682864
License data	US DailyMed: Metoprolol;
Pregnancy; category	AU: C; ;
Routes of; administration	By mouth, intravenous
Drug class	Beta blocker
ATC code	C07AB02 (WHO) ;
Legal status
Legal status	AU: S4 (Prescription only); CA: ℞-only; UK: POM (Prescription only); US: ℞-only; In general: ℞ (Prescription only);
Pharmacokinetic data
Bioavailability	50% (single dose); 70% (repeated administration)
Protein binding	12%
Metabolism	Liver via CYP2D6, CYP3A4
Elimination half-life	3–7 hours
Excretion	Kidney
Identifiers
	IUPAC name (RS)-1-[4-(2-Methoxyethyl)phenoxy]-3-[(propan-2-yl)amino]propan-2-ol;
CAS Number	51384-51-1 ;
PubChem CID	4171;
IUPHAR/BPS	553;
DrugBank	DB00264 ;
ChemSpider	4027 ;
UNII	GEB06NHM23;
KEGG	D02358 ;
ChEBI	CHEBI:6904 ;
ChEMBL	ChEMBL13 ;
CompTox Dashboard (EPA)	DTXSID2023309 ;
ECHA InfoCard	100.051.952
Chemical and physical data
Formula	C15H25NO3
Molar mass	267.369 g·mol−1
3D model (JSmol)	Interactive image;
Chirality	Racemic mixture
Melting point	120 °C (248 °F)
	SMILES O(c1ccc(cc1)CCOC)CC(O)CNC(C)C;
	InChI InChI=1S/C15H25NO3/c1-12(2)16-10-14(17)11-19-15-6-4-13(5-7-15)8-9-18-3/h4-7,12,14,16-17H,8-11H2,1-3H3 ; Key:IUBSYMUCCVWXPE-UHFFFAOYSA-N ;
	(verify)

Metoprolol, sold under the brand name Lopressor among others, is a medication used to treat angina and a number of conditions involving an abnormally fast heart rate.^[4] It is also used to prevent further heart problems after myocardial infarction and to prevent headaches in those with migraines.^[4] It is a selective β₁ receptor blocker medication.^[4] It is taken by mouth or is given intravenously.^[4]

Common side effects include trouble sleeping, feeling tired, feeling faint, and abdominal discomfort.^[4] Large doses may cause serious toxicity.^[5]^[6] Risk in pregnancy has not been ruled out.^[4]^[7] It appears to be safe in breastfeeding.^[8] The metabolism of metoprolol can vary widely among patients, often as a result of hepatic impairment^[9] or CYP2D6 polymorphism.^[10]

Metoprolol was first made in 1969, patented in 1970, and approved for medical use in 1978.^[11]^[12]^[13] It is on the World Health Organization's List of Essential Medicines.^[14] It is available as a generic medication.^[4] In 2022, it was the sixth most commonly prescribed medication in the United States, with more than 65 million prescriptions.^[15]^[16]

^ "Lopressor Product information". Health Canada. 22 October 2009. Retrieved 20 June 2023.
^ "Metolar 25/50 (metoprolol tartrate) tablet" (PDF). U.S. Food and Drug Administration (FDA). Archived (PDF) from the original on 3 March 2016. Retrieved 5 May 2015.
^ Jasek W, ed. (2007). Austria-Codex (in German) (62nd ed.). Vienna: Österreichischer Apothekerverlag. pp. 916–919. ISBN 978-3852001814.
^ ^a ^b ^c ^d ^e ^f ^g "Metoprolol". The American Society of Health-System Pharmacists. Archived from the original on 12 March 2014. Retrieved 21 April 2014.
^ Pillay VV (2012). "Diuretics, Antihypertensives, and Antiarrhythmics". Modern Medical Toxicology. Jaypee Brothers Publishers. p. 303. ISBN 978-9350259658. Archived from the original on 7 July 2017.
^ Marx JA (2014). "Chapter 152: Cardiovascular Drugs". Rosen's emergency medicine : concepts and clinical practice (8th ed.). Philadelphia: Elsevier/Saunders. ISBN 978-1455706051.
^ "Prescribing medicines in pregnancy database". Australian Government. 3 March 2014. Archived from the original on 8 April 2014. Retrieved 22 April 2014.
^ Medical Toxicology. Lippincott Williams & Wilkins. 2004. p. 684. ISBN 978-0781728454. Archived from the original on 7 July 2017.
^ Regårdh CG, Jordö L, Ervik M, Lundborg P, Olsson R, Rönn O (1981). "Pharmacokinetics of metoprolol in patients with hepatic cirrhosis". Clinical Pharmacokinetics. 6 (5): 375–388. doi:10.2165/00003088-198106050-00004. PMID 7333059. S2CID 1042204.
^ Blake CM, Kharasch ED, Schwab M, Nagele P (September 2013). "A meta-analysis of CYP2D6 metabolizer phenotype and metoprolol pharmacokinetics". Clinical Pharmacology and Therapeutics. 94 (3): 394–399. doi:10.1038/clpt.2013.96. PMC 3818912. PMID 23665868.
^ Cite error: The named reference Lopressor: FDA-Approved Drugs was invoked but never defined (see the help page).
^ Carlsson B, ed. (1997). Technological systems and industrial dynamics. Dordrecht: Kluwer Academic. p. 106. ISBN 978-0792399728. Archived from the original on 3 March 2017.
^ Fischer J, Ganellin CR (2006). Analogue-based Drug Discovery. John Wiley & Sons. p. 461. ISBN 978-3527607495.
^ World Health Organization (2023). The selection and use of essential medicines 2023: web annex A: World Health Organization model list of essential medicines: 23rd list. Geneva: World Health Organization. hdl:10665/371090. WHO/MHP/HPS/EML/2023.02.
^ "The Top 300 of 2022". ClinCalc. Archived from the original on 30 August 2024. Retrieved 30 August 2024.
^ "Metoprolol Drug Usage Statistics, United States, 2013–2022". ClinCalc. Retrieved 30 August 2024.

[1] "Lopressor Product information". Health Canada. 22 October 2009. Retrieved 20 June 2023.

[2] "Metolar 25/50 (metoprolol tartrate) tablet" (PDF). U.S. Food and Drug Administration (FDA). Archived (PDF) from the original on 3 March 2016. Retrieved 5 May 2015.

[Austria-Codex-3] Jasek W, ed. (2007). Austria-Codex (in German) (62nd ed.). Vienna: Österreichischer Apothekerverlag. pp. 916–919. ISBN 978-3852001814.

[AHFS2014-4] ^ ^a ^b ^c ^d ^e ^f ^g "Metoprolol". The American Society of Health-System Pharmacists. Archived from the original on 12 March 2014. Retrieved 21 April 2014.

[5] Pillay VV (2012). "Diuretics, Antihypertensives, and Antiarrhythmics". Modern Medical Toxicology. Jaypee Brothers Publishers. p. 303. ISBN 978-9350259658. Archived from the original on 7 July 2017.

[Rosen2014-6] Marx JA (2014). "Chapter 152: Cardiovascular Drugs". Rosen's emergency medicine : concepts and clinical practice (8th ed.). Philadelphia: Elsevier/Saunders. ISBN 978-1455706051.

[Australian_Government-7] "Prescribing medicines in pregnancy database". Australian Government. 3 March 2014. Archived from the original on 8 April 2014. Retrieved 22 April 2014.

[Medical_Toxicology-8] Medical Toxicology. Lippincott Williams & Wilkins. 2004. p. 684. ISBN 978-0781728454. Archived from the original on 7 July 2017.

[pmid7333059-9] Regårdh CG, Jordö L, Ervik M, Lundborg P, Olsson R, Rönn O (1981). "Pharmacokinetics of metoprolol in patients with hepatic cirrhosis". Clinical Pharmacokinetics. 6 (5): 375–388. doi:10.2165/00003088-198106050-00004. PMID 7333059. S2CID 1042204.

[pmid23665868-10] Blake CM, Kharasch ED, Schwab M, Nagele P (September 2013). "A meta-analysis of CYP2D6 metabolizer phenotype and metoprolol pharmacokinetics". Clinical Pharmacology and Therapeutics. 94 (3): 394–399. doi:10.1038/clpt.2013.96. PMC 3818912. PMID 23665868.

[Lopressor:_FDA-Approved_Drugs-11] Cite error: The named reference Lopressor: FDA-Approved Drugs was invoked but never defined (see the help page).

[Kluwer_Academic-12] Carlsson B, ed. (1997). Technological systems and industrial dynamics. Dordrecht: Kluwer Academic. p. 106. ISBN 978-0792399728. Archived from the original on 3 March 2017.

[13] Fischer J, Ganellin CR (2006). Analogue-based Drug Discovery. John Wiley & Sons. p. 461. ISBN 978-3527607495.

[WHO23rd-14] World Health Organization (2023). The selection and use of essential medicines 2023: web annex A: World Health Organization model list of essential medicines: 23rd list. Geneva: World Health Organization. hdl:10665/371090. WHO/MHP/HPS/EML/2023.02.

[15] "The Top 300 of 2022". ClinCalc. Archived from the original on 30 August 2024. Retrieved 30 August 2024.

[16] "Metoprolol Drug Usage Statistics, United States, 2013–2022". ClinCalc. Retrieved 30 August 2024.

[1]

[2]

[3]

[4]

[5]

[6]

[7]

[8]

[9]

[10]

[11]

[12]

[13]

[14]

[15]

[16]

Our website is made possible by displaying online advertisements to our visitors. Please consider supporting us by disabling your ad blocker.

Metoprolol

Our website is made possible by displaying online advertisements to our visitors.
Please consider supporting us by disabling your ad blocker.